Venture NAV Tracker / Private company
Maze Therapeutics, Inc.
Headquarters—
Founded—
Last known round—
Reported valuation—
Cross-fund comparison
Current disclosed marks
One latest disclosed debt mark per fund.
| Fund | Security type / basis | Principal | Fair value | FV / principal | Rate | Maturity | Mark age vs round | Non-accrual |
|---|---|---|---|---|---|---|---|---|
| HTGCHercules Capital, Inc. | senior secured loanFair Value — Senior Secured | $28MMar 31, 2026 · source ↗ | $27.8MMar 31, 2026 · source ↗ | 99.2%Mar 31, 2026 · source ↗ | Prime + 0.95 %, Floor rate 7.95 %, 6.45 % Exit FeeMar 31, 2026 · source ↗ | Feb 1, 2031Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.